We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is it Time to Hold on to Community Health Systems Stock?
Read MoreHide Full Article
Key Takeaways
Community Health posts stronger occupancy, reaching 53.4% on average in the first half of 2025.
Higher revenue per admission and divestitures support streamlined growth.
Operating cash flow is projected at $600-$700M in 2025, up from $480M last year.
Community Health Systems, Inc. (CYH - Free Report) remains a stock worth holding, backed by growing occupancy, revenue per admission and business streamlining efforts. With the aging U.S. population fueling demand for healthcare services, the Franklin, TN-based operator of general acute care hospitals and outpatient facilities is positioned for steady growth. The company currently carries a market cap of $392.3 million.
Courtesy of solid prospects, this Zacks Rank #3 (Hold) stock is worth holding on to at the moment.
Growth Drivers
Community Health continues to focus on investing in high-return markets, which should help capture rising healthcare demand. Occupancy rates have steadily improved, reaching 52.5% in 2024 and averaging 53.4% in the first half of 2025. We expect this to climb to 54.8% by year-end.
Revenue per adjusted admission is trending higher, helping offset softer admissions volumes. To streamline operations, CYH has been actively divesting non-core assets, including the $260 million sale of Florida hospitals to AdventHealth in early 2025. The company is also pursuing the sale of a three-hospital portfolio in Pennsylvania after an earlier deal collapsed.
The company’s cash flow situation is expected to strengthen this year. Net operating cash flow is forecasted within $600-$700 million for 2025, up from $480 million last year, reflecting growing strength in operations.
Zacks Estimates for CYH
Analysts see a sharp rebound ahead. The Zacks Consensus Estimate calls for a 67% earnings improvement in 2025 from last year’s loss of 34 cents per share, followed by another 45.6% gain in 2026. Revenue estimates stand at $12.4 billion for 2025 and $12.7 billion for 2026.
Still, the stock has slipped 6.4% year-to-date, compared with a 27.6% rally in the broader industry. On valuation, CYH trades at a forward 12-month price-to-sales ratio of just 0.03X, far below the industry average of 0.83X. CYH carries a Value Score of A.
Community Health Systems, Inc. Price and Consensus
There are a few factors that investors should keep an eye on.
Balance sheet weakness can affect Community Health's financial flexibility. It exited the second quarter with cash and cash equivalents of $456 million, while long-term debt amounted to $10.8 billion. Its net debt-to-EBITDA of 8.3% is higher than the industry average of 3.3%. Profitability also lags, with return on invested capital at 6.5% versus the industry’s 13.4%. Nevertheless, we believe that a systematic and strategic plan of action will drive long-term growth.
The Zacks Consensus Estimate for Tenet Healthcare’s 2025 full-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in each of the past four quarters, with an average surprise of 31.2%. Also, the consensus mark for Tenet Healthcare’s 2025 full-year revenues suggests 2.4% year-over-year growth.
The consensus mark for Encompass Health’s 2025 full-year earnings indicates 18.3% year-over-year growth. The earnings estimate has witnessed seven upward estimate revisions in the past month, against no movement in the opposite direction. Furthermore, the consensus estimate for Encompass Health’s 2025 full-year revenues suggests 10.2% year-over-year growth.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Is it Time to Hold on to Community Health Systems Stock?
Key Takeaways
Community Health Systems, Inc. (CYH - Free Report) remains a stock worth holding, backed by growing occupancy, revenue per admission and business streamlining efforts. With the aging U.S. population fueling demand for healthcare services, the Franklin, TN-based operator of general acute care hospitals and outpatient facilities is positioned for steady growth. The company currently carries a market cap of $392.3 million.
Courtesy of solid prospects, this Zacks Rank #3 (Hold) stock is worth holding on to at the moment.
Growth Drivers
Community Health continues to focus on investing in high-return markets, which should help capture rising healthcare demand. Occupancy rates have steadily improved, reaching 52.5% in 2024 and averaging 53.4% in the first half of 2025. We expect this to climb to 54.8% by year-end.
Revenue per adjusted admission is trending higher, helping offset softer admissions volumes. To streamline operations, CYH has been actively divesting non-core assets, including the $260 million sale of Florida hospitals to AdventHealth in early 2025. The company is also pursuing the sale of a three-hospital portfolio in Pennsylvania after an earlier deal collapsed.
The company’s cash flow situation is expected to strengthen this year. Net operating cash flow is forecasted within $600-$700 million for 2025, up from $480 million last year, reflecting growing strength in operations.
Zacks Estimates for CYH
Analysts see a sharp rebound ahead. The Zacks Consensus Estimate calls for a 67% earnings improvement in 2025 from last year’s loss of 34 cents per share, followed by another 45.6% gain in 2026. Revenue estimates stand at $12.4 billion for 2025 and $12.7 billion for 2026.
Still, the stock has slipped 6.4% year-to-date, compared with a 27.6% rally in the broader industry. On valuation, CYH trades at a forward 12-month price-to-sales ratio of just 0.03X, far below the industry average of 0.83X. CYH carries a Value Score of A.
Community Health Systems, Inc. Price and Consensus
Community Health Systems, Inc. price-consensus-chart | Community Health Systems, Inc. Quote
Key Concerns
There are a few factors that investors should keep an eye on.
Balance sheet weakness can affect Community Health's financial flexibility. It exited the second quarter with cash and cash equivalents of $456 million, while long-term debt amounted to $10.8 billion. Its net debt-to-EBITDA of 8.3% is higher than the industry average of 3.3%. Profitability also lags, with return on invested capital at 6.5% versus the industry’s 13.4%. Nevertheless, we believe that a systematic and strategic plan of action will drive long-term growth.
Better-Ranked Players
Some better-ranked stocks in the Medical space include Tenet Healthcare Corporation (THC - Free Report) and Encompass Health Corporation (EHC - Free Report) . While Tenet Healthcare sports a Zacks Rank #1 (Strong Buy) at present, Encompass Health carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Tenet Healthcare’s 2025 full-year earnings indicates a 30.8% year-over-year increase. It beat earnings estimates in each of the past four quarters, with an average surprise of 31.2%. Also, the consensus mark for Tenet Healthcare’s 2025 full-year revenues suggests 2.4% year-over-year growth.
The consensus mark for Encompass Health’s 2025 full-year earnings indicates 18.3% year-over-year growth. The earnings estimate has witnessed seven upward estimate revisions in the past month, against no movement in the opposite direction. Furthermore, the consensus estimate for Encompass Health’s 2025 full-year revenues suggests 10.2% year-over-year growth.